News & Trends - Pharmaceuticals
PBS process improvements impacted by COVID-19

Pharma News: On 12 February 2020, the Department of Health hosted a webinar to commence broad consultation on proposed fee changes for Pharmaceutical Benefits Scheme (PBS) and National Immunisation Plan (NIP) listings.
This was followed by a public consultation period from 17 February to 16 March 2020.
As outlined at the webinar and in the consultation document, Stage 2 PBS process improvements and supporting cost recovery arrangements were to be implemented from 1 July 2020, pending Government agreement.
Overview of Stage 2 PBS Process Improvements
- Changes to initial submission categories (including introduction of a single submission date)
- Introduction of resubmission pathways for submissions not recommended by the PBAC
- Revised cost recovery arrangements to support implementation of Stage 2 process improvements.
- Other improvements, including IT system changes
You may also like PRIME Awards 2020 call for entries – the only awards program dedicated to recognising excellence within Australian healthcare communications, is now open for entries.
The current COVID-19 pandemic may impact the government approval of Stage 2 PBS process improvements and supporting cost recovery arrangements and a 1 July 2020 implementation date is now unlikely.
As a result, applicants should be prepared for the current processes and the 2020-21 fees indicated in the 2019-20 Cost Recovery Implementation Statement (CRIS) and the Regulations, pending government approval of some minor amendments, to commence from 1 July 2020. These proposed 2020-21 fees were included in consultations last year.
A 2020-21 CRIS, which will outline the fees to apply from 1 July 2020 will be released as soon as possible.
Register FREE and join 22,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.
News & Trends - Pharmaceuticals

Government’s long-awaited response to The New Frontier report unveiled after two-year wait
Pharma News: The Albanese Government has tabled its response to the House of Reps inquiry and The New Frontier report […]
MoreNews & Trends - Pharmaceuticals

Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’
Pharma News: On World AIDS Day, the National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have […]
MoreNews & Trends - Pharmaceuticals

AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years
Pharma News: AbbVie’s Rinvoq (upadacitinib), a once-daily tablet, has been officially listed on the Pharmaceutical Benefits Scheme (PBS) for adult […]
More